Profilo
Thomas J.
Palermo served as the Chief Executive Officer at ReVascular Therapeutics, Inc. and Ulcerx Medical, Inc. He also worked as the Vice President of Operations & Engineering at Ensure Medical, Inc. Palermo was the Chief Operating Officer at Dextera Surgical, Inc. from 2015 to 2018.
He completed his undergraduate degree from Southern New Hampshire University.
Precedenti posizioni note di Tom Palermo
| Società | Posizione | Fine |
|---|---|---|
| DEXTERA SURGICAL INC | Direttore operativo | 01/03/2018 |
Ensure Medical, Inc.
 Ensure Medical, Inc. Medical SpecialtiesHealth Technology Ensure Medical, Inc is a privately held company that develops devices for postcatheterization closure of the femoral artery. Its technology is based on a biodegradable closure device and a delivery system. The company was incorporated in 2002 and is headquartered in Sunnyvale, CA. | Direttore operativo | - |
| Ulcerx Medical, Inc. | Amministratore Delegato | - |
ReVascular Therapeutics, Inc.
 ReVascular Therapeutics, Inc. Medical SpecialtiesHealth Technology ReVascular Therapeutics, Inc. used to develop and manufacture medical devices. It offers TRUEPATH, an intraluminal chronic total occlusion crossing device enabling endovascular treatment in cases that typically cannot be treated with standard endovascular devices. The company was founded in 2006 by Carl Simpson, Menahem Nassi and Gerardo V. Noriega and is headquartered in Sunnyvale, CA. | Amministratore Delegato | - |
Formazione di Tom Palermo
| Southern New Hampshire University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Ensure Medical, Inc.
Ensure Medical, Inc. Medical SpecialtiesHealth Technology Ensure Medical, Inc is a privately held company that develops devices for postcatheterization closure of the femoral artery. Its technology is based on a biodegradable closure device and a delivery system. The company was incorporated in 2002 and is headquartered in Sunnyvale, CA. | Health Technology |
ReVascular Therapeutics, Inc.
ReVascular Therapeutics, Inc. Medical SpecialtiesHealth Technology ReVascular Therapeutics, Inc. used to develop and manufacture medical devices. It offers TRUEPATH, an intraluminal chronic total occlusion crossing device enabling endovascular treatment in cases that typically cannot be treated with standard endovascular devices. The company was founded in 2006 by Carl Simpson, Menahem Nassi and Gerardo V. Noriega and is headquartered in Sunnyvale, CA. | Health Technology |
Dex Liquidating Co.
 Dex Liquidating Co. Medical SpecialtiesHealth Technology Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. It specializes in robotic-assisted surgery and medical devices. The company was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
| Ulcerx Medical, Inc. |
- Borsa valori
- Insiders
- Tom Palermo
